Serial perioperative measurements of inflammatory and oxidative stress markers, such as interleukin-6, myeloperoxidase, or circulating microRNAs, may provide superior discriminatory power compared with static CRP values and clarify the mechanistic links between OSA and perioperative vulnerability. This evidence concerns the gene MPO and obstructive sleep apnea syndrome.